Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Child psychopharmacology: politics versus science.

Levy F.

Aust N Z J Psychiatry. 2013 Oct;47(10):961. doi: 10.1177/0004867413498938. Epub 2013 Jul 25. No abstract available.

PMID:
23888073
2.

Politics vs practice: commentary on the ADHD debate.

Levy F.

Aust N Z J Psychiatry. 2013 Jan;47(1):89-91. doi: 10.1177/0004867412459811. No abstract available.

PMID:
23293313
3.

Commentary on Levy (2012) politics vs practice: withdrawal of the draft NHMRC ADHD guidelines.

Starling J.

Aust N Z J Psychiatry. 2013 Jan;47(1):91-2. doi: 10.1177/0004867412459570. No abstract available.

PMID:
23293314
4.

Time for some reason in the ADHD debate.

Starling J.

Aust N Z J Psychiatry. 2013 Oct;47(10):958-9. doi: 10.1177/0004867413498272. Epub 2013 Jul 25. No abstract available.

PMID:
23888075
5.

Response to Whitely: a caution from the coalface.

Levy F.

Aust N Z J Psychiatry. 2012 May;46(5):404-6. doi: 10.1177/0004867412444108. No abstract available.

PMID:
22535290
6.

ADHD debate clouded by preconceptions and undisclosed conflicts of interest.

Whitely M.

Aust N Z J Psychiatry. 2013 Oct;47(10):956-8. doi: 10.1177/0004867413498270. Epub 2013 Jul 25. No abstract available.

PMID:
23888076
7.

The ADHD debate: to bury national guidelines or to praise them?

Paterson R.

Aust N Z J Psychiatry. 2013 Oct;47(10):959-60. doi: 10.1177/0004867413498271. Epub 2013 Jul 25. No abstract available.

PMID:
23888074
8.
9.

The rise and fall of ADHD child prescribing in Western Australia: lessons and implications.

Whitely M.

Aust N Z J Psychiatry. 2012 May;46(5):400-3. doi: 10.1177/0004867412444864. No abstract available.

PMID:
22535289
10.

ADHD in Western Australia: an iatrogenic 'epidemic' cured by bureaucracy? Time to focus on the facts.

Paterson R.

Aust N Z J Psychiatry. 2013 Jan;47(1):88-9. doi: 10.1177/0004867412459894. No abstract available.

PMID:
23293312
11.

Trends in the prescribing of stimulant medication for the treatment of Attention Deficit Hyperactivity Disorder in adults in New South Wales.

New South Wales Department of Health.

N S W Public Health Bull. 2004;15 Suppl 3:1-55. No abstract available.

PMID:
15448720
12.

The difference between efficacy and effectiveness research in studying attention-deficit/hyperactivity disorder.

Wolraich ML.

Arch Pediatr Adolesc Med. 1999 Dec;153(12):1220-1. No abstract available.

PMID:
10591296
13.

Evidence and belief in attention deficit hyperactivity disorder. Reintroduction of methylphenidate in Italy needs careful monitoring.

Bonati M, Impicciatore P, Pandolfini C.

BMJ. 2001 Mar 3;322(7285):556. No abstract available.

PMID:
11263458
14.

Innovations and recent trends in the treatment of ADHD.

Madaan V, Kinnan S, Daughton J, Kratochvil CJ.

Expert Rev Neurother. 2006 Sep;6(9):1375-85. Review.

PMID:
17009924
15.

Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges.

Power TJ, Mautone JA, Manz PH, Frye L, Blum NJ.

Pediatrics. 2008 Jan;121(1):e65-72. doi: 10.1542/peds.2007-0383.

PMID:
18166546
16.
17.

Stimulating: prescribing amidst controversy.

Martin A.

Am J Psychiatry. 2006 Apr;163(4):574-7. No abstract available.

PMID:
16585428
18.

Massive variation in Ritalin prescribing.

Gainsbury S.

Health Serv J. 2008 Jul 17:5. No abstract available.

PMID:
18705035
19.

Stimulants in AD/HD, a controversial treatment only in Sweden?

Ekman JT, Gustafsson PA.

Eur Child Adolesc Psychiatry. 2000 Dec;9(4):312-3. No abstract available.

PMID:
11202108
20.

Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.

Janols LO, Liliemark J, Klintberg K, von Knorring AL.

Nord J Psychiatry. 2009 Nov;63(6):508-16. doi: 10.3109/08039480903154534.

PMID:
19958258

Supplemental Content

Support Center